Regeneron Pharmaceuticals Inc
1
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-08-26 to 2026-08-26
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-08-26 | FDA Drug | FDA Recall: Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution | Regeneron Pharmaceuticals Inc | Class II | N/A |